Shanti Eswaran is a Gastroenterology physician affiliated with University of Michigan. OpenAlex indexes 93 publications with 3,806 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Medical Center Dr
Ann Arbor, MI 481095000
Telephone
734-936-4000Registry record last updated 24 Jun 2019.
Clinical trials
- Kiwifruit, Prunes, & Fiber for Abdominal and Bowel Symptoms in US Patients With Chronic Constipation
Sponsor: University of Michigan
- Diet Reintroduction Study in Irritable Bowel Syndrome
Sponsor: University of Michigan
- Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Exact Sciences CorporationProgram year20241 payment
- Ardelyx, Inc.Program year20231 payment
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
65.5%Proton pump inhibitor13.2%Omeprazole50%Pantoprazole Sodium26%Dexlansoprazole Dr13%Esomeprazole Magnesium11%Part D<11 patientsGuanylate Cyclase-C Agonist10.8%Linzess88%Trulance12%Part D<11 patients+ 11 more classes in this area
Blood & clotting
9.5%Solutions for parenteral nutrition7.4%Peg 3350-Electrolyte100%Part D≥66 patientsSalt solutions2.1%Sodium Chloride100%Part D<11 patientsRespiratory
8.8%Histamine-1 Receptor Antagonist5.1%Diphenhydramine Hcl100%Part D<11 patientsPhenothiazine2.3%Promethazine Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- All FODMAPs Aren’t Created Equal: Results of a Randomized Reintroduction Trial in Patients With Irritable Bowel Syndrome
Clinical Gastroenterology and Hepatology
2024 - Percutaneous electrical nerve field stimulation for adolescents with irritable bowel syndrome: Cost‐benefit and cost‐minimization analysis
Journal of Pediatric Gastroenterology and Nutrition
2024 - S536 Prevalence of Disaccharidase Deficiencies in Adults With Irritable Bowel Syndrome and Functional Diarrhea: Interim Analysis From a Multicenter, Prospective U.S. Trial
The American Journal of Gastroenterology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”